Cancer Education

Hematology-Oncology Fellowship
MD/PhD Program
For Nurses
For Pharmacists
Hematology-Oncology Fellowship

Hematology-Oncology Fellowship

Our fellows are given the structure and supervision required to ensure that each are well-trained, competent hematologists and oncologists, and are given guidance and mentorship toward their individual professional goals and aspirations.
Hematology-Oncology Fellowship
Learn More
MD/PhD Program

Texas A&M MD/PhD Program

tudents pursuing an MD/PhD degree have the opportunity to enroll in medical and graduate science classes at Texas A&M Institute for Biosciences and Technology (IBT) in Houston and complete three to four years of doctoral thesis work with a faculty mentor at Houston Methodist Research Institute.
Texas A&M MD/PhD Program
Learn More
For Nurses

Action STAT Boot Camp for Nurse Practitioners and Physician Assistants

Action STAT is a boot camp-style weekend course that offers need-to-know information for nurse practitioners and physician assistants practicing in a hospital-based setting. The conference will present the latest evidence in the diagnosis and treatment of important topics in several areas, including hematology-oncology.
Action STAT Boot Camp
Learn More
For Pharmacists

PGY2 Oncology Pharmacy Residency

This residency program provides advanced training for pharmacists in the fields of oncology, malignant and benign hematology, and blood and marrow transplantation.
PGY2 Oncology Pharmacy Residency
Learn More

79

Faculty With Academic Appointments

202

Peer-reviewed Publications in 2023
Recent Cancer Research
Breast Cancer Cells
Nanomedicine Makes Big Strides in the Fight Against Breast Cancer
Researchers deliver immunotherapy directly into triple-negative breast cancer tumors with nanofluidic implants, achieving tunable and sustained dosing of immunotherapeutics with high anti-tumor activity.
Predicting the Future of Cancer Treatment

Houston Methodist faculty developed a multiscale mechanistic model to further investigate the role of miR-155 in non-small cell lung cancer and predict clinical efficacy based on preclinical data.

New Perspectives in Pancreatic Cancer Management

Molecular alterations found in pancreatic ductal adenocarcinoma samples may have potential therapeutic implications

woman sitting near an MRI machine
CPRIT Funds Cancer Research

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded $3.4 million in funding to two Houston Methodist cancer researchers for projects to improve cancer prevention in underserved communities and advance the development of more effective multiple myeloma treatments.

man and healthcare worker looking over clipboard
Therapies for Localized Prostate Cancer
Houston Methodist Researchers Examine Two Therapeutic Strategies And Their Impact On Survival For Localized Prostate Cancer.
half-smoked cigarette on empty background
Cell Division Aberrations Caused by Cigarette Smoke Could Help Detect Cancer Early

Houston Methodist researchers have found that exposure to cigarette smoke can induce both centrosome amplification and clustering in normal lung epithelial cells, making them cancerlike.

man talking to healthcare worker
An Ongoing Phase II Clinical Trial for Bladder Cancer
Combining Neoadjuvant Drug Sasanlimab and Stereotactic Body Radiotherapy May Improve The Quality Of Life In Muscle-Invasive Bladder Cancer Patients

Explore the following:

Donate to Houston Methodist

With your support, Houston Methodist provides exceptional research, education, and care that is truly leading medicine.

Donate Now